A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection

A review of pathophysiological mechanism, diagnosis, and treatment of thrombosis risk associated with COVID-19 infection

Severe coronavirus (COVID-19) infection has been reportedly associated with a high risk of thromboembolism. Developing macrovascular thrombotic complications, including myocardial injury/infarction, venous thromboembolism, and stroke have been observed in one-third of severe COVID-19 hospitalized pa...

Full description

Bibliographic Details
Main Author:	Sahar Vahdat
Format:	Article
Language:	English
Published:	Elsevier 2022-08-01
Series:	International Journal of Cardiology: Heart & Vasculature
Subjects:	COVID-19 Thrombosis Anticoagulation Inflammation
Online Access:	http://www.sciencedirect.com/science/article/pii/S2352906722001178

Similar Items

Pulmonary Thrombosis despite Therapeutic Anticoagulation in COVID-19 Pneumonia: A Case Report and Literature Review
by: Cristian-Mihail Niculae, et al.
Published: (2023-07-01)

Comparison of safety and efficacy between therapeutic or intermediate versus prophylactic anticoagulation for thrombosis in COVID-19 patients: a systematic review and meta-analysis
by: Hyeon-Jeong Lee, et al.
Published: (2023-05-01)

Portal vein thrombosis in patients with COVID-19: A systematic review
by: Hany Abdelfatah El-hady, et al.
Published: (2023-08-01)

Non-vitamin K antagonist oral anticoagulants for COVID-19 thrombosis
by: Adel Khalifa Sultan Hamad
Published: (2022-01-01)

Cerebral Venous Sinus Thrombosis as a Presentation of COVID-19
by: Christopher Hughes, et al.
Published: (2020-04-01)

A proposal for staging COVID‐19 coagulopathy
by: Jecko Thachil, et al.
Published: (2020-07-01)

Anticoagulation in COVID-19: a single-center retrospective study
by: Sohaib Sanan Roomi, et al.
Published: (2021-01-01)

Frequently Asked Questions about Thrombosis during COVID-19 Pandemic
by: Lolita Golemi, et al.
Published: (2020-10-01)

The Diagnosis and Treatment of Cerebral Venous Thrombosis
by: Dilaver Kaya
Published: (2017-09-01)

Recurrent upper extremity arterial thrombosis preceding a diagnosis of COVID-19
by: Raymond Kennedy, et al.
Published: (2023-03-01)

Therapeutic anticoagulation to prevent thrombosis, coagulopathy, and mortality in severe COVID‐19: The Swiss COVID‐HEP randomized clinical trial
by: Marc Blondon, et al.
Published: (2022-05-01)

Overview of COVID-19’s relationship with thrombophilia proteins
by: Aydin Suna, et al.
Published: (2021-12-01)

Caging the dragon: Research approach to COVID‐19–related thrombosis
by: Marieke J. H. A. Kruip, et al.
Published: (2021-02-01)

COVID-19-RELATED ARTERIAL THROMBOSIS
by: O. NEMATZODA, et al.
Published: (2021-03-01)

Acute Pulmonary Artery Thrombosis despite Anticoagulation in Patients with COVID-19 Pneumonia: A Single-Center Retrospective Cohort Study
by: Cristian-Mihail Niculae, et al.
Published: (2022-05-01)

Efficacy and safety of increased doses of anticoagulants in COVID-19 patients: A systematic review and meta-analysis
by: Evgeny Stepanov, et al.
Published: (2022-01-01)

Clinical Outcomes of Anticoagulant Therapy in COVID-19 Patients with Pre-Existing Cardiovascular Diseases: A Systematic Review
by: Alhawiti NM, et al.
Published: (2023-06-01)

Platelets and Their Role in Hemostasis and Thrombosis—From Physiology to Pathophysiology and Therapeutic Implications
by: Alina Scridon
Published: (2022-10-01)

Prevention of thrombotic risk in hospitalized patients with COVID-19 and hemostasis monitoring
by: Sophie Susen, et al.
Published: (2020-06-01)

Left ventricular thrombosis and endogenous endophthalmitis in the setting of COVID‐19: A case report
by: Mohammad Javad Zibaeenezhad, et al.
Published: (2022-05-01)

Characteristics and treatment of coagulopathy associated with COVID-19
by: Miljić Predrag
Published: (2021-01-01)

Lupus anticoagulant associates with thrombosis in patients with COVID‐19 admitted to intensive care units: A retrospective cohort study
by: Tessa Noordermeer, et al.
Published: (2022-08-01)

Thrombosis and bleeding outcomes in the treatment of cerebral venous thrombosis in cancer
by: Nadia I Abelhad, et al.
Published: (2021-06-01)

The Challenging Anticoagulant Therapy in COVID19 Patient with Associated Coagulopathy
by: Raissa Virgy Rianda, et al.
Published: (2021-07-01)

Thrombophilia as a Risk Factor for Thrombosis
by: Stepan Henyk, et al.
Published: (2020-03-01)

Comparison of published guidelines for management of coagulopathy and thrombosis in critically ill patients with COVID 19: implications for clinical practice and future investigations
by: Adam Flaczyk, et al.
Published: (2020-09-01)

Prevalence and risk factors of thrombotic events on patients with COVID-19: a systematic review and meta‐analysis
by: Xiaoming Xiong, et al.
Published: (2021-05-01)

Venous and arterial thrombosis in COVID-19: An updated narrative review
by: Zainab Al Duhailib, et al.
Published: (2022-06-01)

Pulmonary embolism as a complication in a patient with COVID-19 infection
by: Đuričin Aleksandar, et al.
Published: (2021-01-01)

A review of the pathological mechanisms and clinical implications of coagulopathy in COVID-19
by: Suvir Singh, et al.
Published: (2021-01-01)

Therapeutic considerations for prevention and treatment of thrombotic events in COVID-19
by: Faria Khimani, et al.
Published: (2023-03-01)

COVID-19 and Antipsychotic Therapy: Unraveling the Thrombosis Risk
by: Eszter-Anna Dho-Nagy, et al.
Published: (2024-01-01)

Management of the thrombotic risk associated with COVID-19: guidance for the hemostasis laboratory
by: M. Hardy, et al.
Published: (2020-09-01)

Pathophysiological mechanisms of thrombosis in acute and long COVID-19
by: Haijiao Jing, et al.
Published: (2022-11-01)

The Hemostatic System in Newborns and the Risk of Neonatal Thrombosis
by: Jamilya Khizroeva, et al.
Published: (2023-09-01)

Overview of the pharmaceutical market of anticoagulants for the treatment of coronavirus disease (COVID-19) during marital state in Ukraine
by: O. M. Zaliska, et al.
Published: (2022-10-01)

Role of Therapeutic Anticoagulation in COVID-19: The Current Situation
by: Mandeep Singh Rahi, et al.
Published: (2023-06-01)

VENOUS THROMBOSIS AND PULMONARY EMBOLISM
by: I. N. Bokarev, et al.
Published: (2011-08-01)

COVID-19 and Thrombosis Predisposition
by: Gerculy Renata, et al.
Published: (2020-09-01)

Major bleeding after pronation in severe COVID-19 patient
by: Rosanna Carmela De Rosa, et al.
Published: (2021-02-01)